SpotLight©

Health Screening With SpotLight©

isbrg reimagines health screening with its non-invasive SpotLight© technology platform, setting a new standard for access, cost, and stress-free approaches. The SpotLight© platform's innovative approach and continually evolving technology provides a deeper understanding of the body's intricate states of being, shedding light on previously inaccessible information. By leveraging its sophisticated analytical capabilities, SpotLight© untangles the complexity of individual health profiles, enabling personalized and effective interventions.

SpotLight© Platform Solutions

  • Non-invasive

    The non-invasive nature of SpotLight© ushers in a new level of patient comfort to the screening process, ensuring a more pleasant experience versus current chemical reagent and radiation methods.

  • Real-time health data

    SpotLight© offers immediate results without the need for invasive procedures and time consuming laboratory testing. SpotLight© allow for prompt intervention - potentially improving treatment outcomes.

  • Environmentally friendly

    SpotLight© represents a significant advancement in environmental stewardship by completely eliminating the production of hazardous chemical reagent waste generated from current tests.

  • Expandable technology platform

    With SpotLight©'s advanced algorithms, non-invasive design and unique method of health screening, the technology platform is easily expandable. This ensures the technology remains current with new and ever evolving viruses and diseases.

  • No expiry date

    Unlike current chemical reagent screening methods, SpotLight© is not limited by shelf life, avoiding the need for the costly disposal required for chemical reagent tests, which not only reduces environmental impact but also minimizes logistical challenges in test distribution, financial losses and inventory management.

  • Low cost per test

    The low per test cost of SpotLight© provides financial relief to global health systems already in economic distress, enabling wider access for vulnerable populations worldwide. The low cost per test also provides access for individuals unable to afford the high cost of blood tests based on chemical reagents.